Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals is a world leader in the emerging field of drug-eluting medical devices and bio-materials. Headquartered in Vancouver, Angiotech's operations include 45 legal entities in eight countries with total assets over $1 billion. Financially stable, the Company has recently completed seven acquisitions with more planned. Last year, it acquired American Medical Instruments Holdings, Inc. for $787.9 million. With the addition of 1400 new AMI staff, Angiotech expanded its business to include the production and distribution of medical devices.
Prospective Students
